O SlideShare utiliza cookies para otimizar a funcionalidade e o desempenho do site, assim como para apresentar publicidade mais relevante aos nossos usuários. Se você continuar a navegar o site, você aceita o uso de cookies. Leia nosso Contrato do Usuário e nossa Política de Privacidade.
O SlideShare utiliza cookies para otimizar a funcionalidade e o desempenho do site, assim como para apresentar publicidade mais relevante aos nossos usuários. Se você continuar a utilizar o site, você aceita o uso de cookies. Leia nossa Política de Privacidade e nosso Contrato do Usuário para obter mais detalhes.
Prajith.V PharmD @Sri Ramakrishna Institute
of Paramedical Sciences
PCI President Dr B Suresh who brought Doctor of Pharmacy
Program to India
About 62% of licensed pharmacists work in community
pharmacies and 23% work in hospitals
About 71% of Pharmacy Technician jobs are in pharmacies,
grocery stores, department stores, or mass retailers.
Pharmacy council of India started the programme in
the year 2008 with a good intention to improve the
pharmacy services in the Indian healthcare system
and to increase the dignity of the profession. But,
from the beginning a group of people have been
raising allegations about the way the programme
was introduced and the way it is disturbing the
smooth running of the course putting the students
into a quandary.
A Pharm D graduate could find jobs mostly related
to the clinical force of India. With gradual
amendments being made in the health care
industry, the Pharm D graduate could play an
active role in heading the Hospital Pharmacy
Setting (Hospital Setting / Hospital Pharmacy.
Also with a large number of Pharmaceutical
companies opting for clinical trials the industry is
heading towards a business worth 1.4 billion by
way of clinical trials.
The Federation of Indian Pharmacists Organization (FIPO) has urged
the Department of Personnel & Training (DoPT), government of
India to revise the Rule 51 of the Central Civil Services Leave Rules
(CCS) in order to facilitate the pharmacists in the central
government health services to pursue higher studies in pharmacy,
especially the three-year Pharm D (PB) programme
Pharmacovigilance Programme of India launched on July 14,
2010 is currently capturing ADR data in Indian population in a
systematic way in coordination with the IPC. The main
objective of the Programme is to monitor ADRs in Indian
Safety Monitoring of Medicinal Products
Pharmacovigilance (PV or PhV), also known as Drug Safety
All medicines have risks as well as benefits. The aim of
Pharmacovigilance 1 is to protect public health by
identifying, evaluating, managing and minimizing safety
Issues to ensure that the overall benefits of medicines
outweigh the risks.
Patient safety is a fundamental principle
Apply computerized statistical tool s to facilitate the
evaluation of safety information through, for example, the
identification of unexpected adverse events that are being
reported on a disproportionate basis (safety signals)
The science of Pharmacovigilance is continuously evolving
and is actively involved in working with industry, regulators,
healthcare professionals and patients to enhance
methodologies in this area
Drug Technical Advisory Board (DTAB) set up Vigilance
Forensic Pharmacy and Forensic Psychology
Adverse Drug Reactions (ADRs)
Clinical Trial Safety
In this regard, IPC which acts as the national coordination
centre (NCC) for Pharmacovigilance Program of India (PvPI)
already had a series of strategic meetings with the Centre
over the last few months.
Since 2011, around 1,10,000 adverse drug reactions have
been reported from across the country. However, this was
after the government made it mandatory for hospitals to
have a pharmacovigilance cell. Still, officials say, there are
only few hospitals across the country operating with a
Currently, there are only 150 hospitals across the country
which have pharmacovigilance cell, the official cell.
However, the health ministry and the drug regulator are
making efforts to ramp up such cells.